Supplementary Data 1 from Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
收藏数据链接：
官方服务：
资源简介：
Tumor size and body weight measurements by day
创建时间：
2023-12-15
